Back to results
US 2026/0091192 A1Published application
Methods to increase functional capacity and quality of life in bronchietasis patients with nontuberculous mycobacteria
AssigneeMalllinckrodt Pharmaceuticals Ireland Limited
InventorsJames Potenziano, Christopher Miller
Life of this patent
Estimating the term…
Abstract
Provided herein are method of treating a patient with nontuberculous mycobacteria by administering nitric oxide to the patient for at least 100 days to increase functional capacity and quality of life of the patient.
Claims20
A method of treating a patient with nontuberculous mycobacteria with intelligent dosing, comprising:
- administering a first amount of nitric oxide gas to the patient for a first period of time;
- evaluating one or more intelligent dosing factors selected from the group consisting of blood oxygen content, oxygen dilution, methemoglobin, and methemoglobin reductase;
- and
- administering a second amount of nitric oxide gas for a second period of time based on the one or more intelligent dosing factors.
1 more element
Dependencies are inferred from the claim text.